| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T0 |
0-10 |
NEGREG |
denotes |
Overcoming |
| T1 |
35-47 |
DISEASE |
denotes |
osteosarcoma |
| T2 |
60-78 |
GENE |
denotes |
miR-199a-modulated |
| T3 |
79-89 |
NEGREG |
denotes |
inhibition |
| T4 |
93-99 |
GENE |
denotes |
HIF-1α |
| T5 |
93-103 |
GENE |
denotes |
HIF-1α.
Dy |
| T6 |
101-114 |
VAR |
denotes |
Dysregulation |
| T7 |
118-127 |
GENE |
denotes |
microRNAs |
| T8 |
146-156 |
REG |
denotes |
contribute |
| T9 |
206-215 |
REG |
denotes |
correlate |
| T10 |
227-232 |
DISEASE |
denotes |
progr |
| T11 |
243-252 |
CPA |
denotes |
prognosis |
| T12 |
254-262 |
GENE |
denotes |
MiR-199a |
| T13 |
284-296 |
REG |
denotes |
dysregulated |
| T14 |
314-319 |
DISEASE |
denotes |
type |
| T15 |
335-346 |
REG |
denotes |
association |
| T16 |
355-363 |
GENE |
denotes |
miR-199a |
| T17 |
400-412 |
DISEASE |
denotes |
osteosarcoma |
| T18 |
405-416 |
DISEASE |
denotes |
sarcoma is |
| T19 |
462-470 |
GENE |
denotes |
miR-199a |
| T20 |
555-563 |
GENE |
denotes |
miR-199a |
| T21 |
580-583 |
NEGREG |
denotes |
low |
| T22 |
594-606 |
DISEASE |
denotes |
osteosarcoma |
| T23 |
595-607 |
DISEASE |
denotes |
steosarcoma |
| T24 |
692-704 |
DISEASE |
denotes |
osteosarcoma |
| T25 |
693-705 |
DISEASE |
denotes |
steosarcoma |
| T26 |
730-741 |
REG |
denotes |
correlation |
| T27 |
750-758 |
GENE |
denotes |
miR-199a |
| T28 |
763-783 |
CPA |
denotes |
cisplatin resistance |
| T29 |
787-799 |
DISEASE |
denotes |
osteosarcoma |
| T30 |
788-800 |
DISEASE |
denotes |
steosarcoma |
| T31 |
831-841 |
NEGREG |
denotes |
attenuated |
| T32 |
842-850 |
GENE |
denotes |
miR-199a |
| T33 |
851-862 |
MPA |
denotes |
expressions |
| T34 |
877-891 |
VAR |
denotes |
overexpression |
| T35 |
895-903 |
GENE |
denotes |
miR-199a |
| T36 |
904-914 |
POSREG |
denotes |
sensitizes |
| T37 |
915-927 |
DISEASE |
denotes |
osteosarcoma |
| T38 |
916-928 |
DISEASE |
denotes |
steosarcoma |
| T39 |
972-978 |
GENE |
denotes |
HIF-1α |
| T40 |
973-983 |
GENE |
denotes |
IF-1α as a |
| T41 |
991-997 |
MPA |
denotes |
target |
| T42 |
1001-1009 |
GENE |
denotes |
miR-199a |
| T43 |
1045-1057 |
DISEASE |
denotes |
osteosarcoma |
| T44 |
1049-1061 |
DISEASE |
denotes |
osarcoma cel |
| T45 |
1086-1094 |
POSREG |
denotes |
elevated |
| T46 |
1095-1101 |
GENE |
denotes |
HIF-1α |
| T47 |
1099-1109 |
GENE |
denotes |
1α express |
| T48 |
1102-1112 |
MPA |
denotes |
expression |
| T49 |
1127-1134 |
DISEASE |
denotes |
We rep |
| T50 |
1143-1157 |
VAR |
denotes |
overexpression |
| T51 |
1161-1169 |
GENE |
denotes |
miR-199a |
| T52 |
1170-1183 |
POSREG |
denotes |
re-sensitizes |
| T53 |
1213-1222 |
CPA |
denotes |
cisplatin |
| T54 |
1231-1241 |
NEGREG |
denotes |
inhibition |
| T55 |
1245-1251 |
GENE |
denotes |
HIF-1α |
| T56 |
1254-1264 |
GENE |
denotes |
vitro and |
| T57 |
1308-1320 |
DISEASE |
denotes |
osteosarcoma |
| T58 |
1320-1332 |
DISEASE |
denotes |
patient sam |
| T59 |
1363-1374 |
REG |
denotes |
correlation |
| T60 |
1383-1391 |
GENE |
denotes |
miR-199a |
| T61 |
1396-1402 |
GENE |
denotes |
HIF-1α |
| T62 |
1408-1418 |
GENE |
denotes |
. Our stud |
| T63 |
1492-1503 |
DISEASE |
denotes |
nd miR-199a |
| T64 |
1495-1503 |
GENE |
denotes |
miR-199a |
| T65 |
1534-1551 |
MPA |
denotes |
therapeutic agent |
| T66 |
1556-1568 |
DISEASE |
denotes |
osteosarcoma |
| T67 |
1577-1589 |
DISEASE |
denotes |
who fail to |
| R0 |
T1 |
T0 |
ThemeOf |
osteosarcoma,Overcoming |
| R1 |
T1 |
T3 |
ThemeOf |
osteosarcoma,inhibition |
| R10 |
T16 |
T15 |
ThemeOf |
miR-199a,association |
| R11 |
T17 |
T15 |
ThemeOf |
osteosarcoma,association |
| R12 |
T20 |
T21 |
ThemeOf |
miR-199a,low |
| R13 |
T22 |
T21 |
ThemeOf |
osteosarcoma,low |
| R14 |
T24 |
T26 |
ThemeOf |
osteosarcoma,correlation |
| R15 |
T27 |
T26 |
ThemeOf |
miR-199a,correlation |
| R16 |
T27 |
T33 |
ThemeOf |
miR-199a,expressions |
| R17 |
T28 |
T26 |
ThemeOf |
cisplatin resistance,correlation |
| R18 |
T28 |
T31 |
ThemeOf |
cisplatin resistance,attenuated |
| R19 |
T29 |
T26 |
ThemeOf |
osteosarcoma,correlation |
| R2 |
T4 |
T3 |
ThemeOf |
HIF-1α,inhibition |
| R20 |
T29 |
T28 |
ThemeOf |
osteosarcoma,cisplatin resistance |
| R21 |
T29 |
T31 |
ThemeOf |
osteosarcoma,attenuated |
| R22 |
T33 |
T31 |
ThemeOf |
expressions,attenuated |
| R23 |
T32 |
T31 |
ThemeOf |
miR-199a,attenuated |
| R24 |
T32 |
T33 |
ThemeOf |
miR-199a,expressions |
| R25 |
T33 |
T26 |
ThemeOf |
expressions,correlation |
| R26 |
T33 |
T36 |
ThemeOf |
expressions,sensitizes |
| R27 |
T34 |
T31 |
CauseOf |
overexpression,attenuated |
| R28 |
T34 |
T36 |
CauseOf |
overexpression,sensitizes |
| R29 |
T35 |
T33 |
ThemeOf |
miR-199a,expressions |
| R3 |
T6 |
T8 |
CauseOf |
Dysregulation,contribute |
| R30 |
T35 |
T34 |
ThemeOf |
miR-199a,overexpression |
| R31 |
T35 |
T36 |
ThemeOf |
miR-199a,sensitizes |
| R32 |
T37 |
T36 |
ThemeOf |
osteosarcoma,sensitizes |
| R33 |
T39 |
T41 |
ThemeOf |
HIF-1α,target |
| R34 |
T42 |
T41 |
ThemeOf |
miR-199a,target |
| R35 |
T48 |
T45 |
ThemeOf |
expression,elevated |
| R36 |
T46 |
T48 |
ThemeOf |
HIF-1α,expression |
| R37 |
T50 |
T52 |
CauseOf |
overexpression,re-sensitizes |
| R38 |
T50 |
T54 |
CauseOf |
overexpression,inhibition |
| R39 |
T51 |
T50 |
ThemeOf |
miR-199a,overexpression |
| R4 |
T6 |
T9 |
CauseOf |
Dysregulation,correlate |
| R40 |
T51 |
T52 |
ThemeOf |
miR-199a,re-sensitizes |
| R41 |
T54 |
T52 |
CauseOf |
inhibition,re-sensitizes |
| R42 |
T53 |
T52 |
ThemeOf |
cisplatin,re-sensitizes |
| R43 |
T55 |
T54 |
ThemeOf |
HIF-1α,inhibition |
| R44 |
T57 |
T59 |
ThemeOf |
osteosarcoma,correlation |
| R45 |
T60 |
T59 |
ThemeOf |
miR-199a,correlation |
| R46 |
T61 |
T59 |
ThemeOf |
HIF-1α,correlation |
| R47 |
T64 |
T65 |
ThemeOf |
miR-199a,therapeutic agent |
| R48 |
T66 |
T65 |
ThemeOf |
osteosarcoma,therapeutic agent |
| R5 |
T7 |
T6 |
ThemeOf |
microRNAs,Dysregulation |
| R6 |
T7 |
T8 |
ThemeOf |
microRNAs,contribute |
| R7 |
T11 |
T8 |
ThemeOf |
prognosis,contribute |
| R8 |
T11 |
T9 |
ThemeOf |
prognosis,correlate |
| R9 |
T12 |
T13 |
ThemeOf |
MiR-199a,dysregulated |
